CDA | Evidence Driven
CDA | Evidence Driven

teriflunomide

Details

Files
Generic Name:
teriflunomide
Project Status:
Active
Therapeutic Area:
Multiple Sclerosis (MS)
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0752-000
Call for patient/clinician input closed:
NOC Status at Filing:
N/A
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
​Radiologically Isolated Syndrome (RIS)
Key Milestones2
Submission received11-Jul-24
Review initiated12-Jul-24
Expert committee meeting (initial)21-Nov-24

Files

Proposed Scope View PDF
Last Updated : October 31, 2024